3/18/2022Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...

3/18/2022EdiGene Licenses from BCH the Methods and Compositions for Boosting Fe...

3/18/2022Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021

3/18/2022Drug R&D and Product Registration News Digest March 2022 (3)

3/18/2022Recent Executive Moves

3/17/2022Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...

3/16/2022Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo

3/16/2022Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...

3/16/2022China Resources Licenses Global Rights of Ab Studio's COVID Antibody ...

3/16/2022PharmCube: An Analysis of NDAs in China

3/16/2022Another Strike for Biotech: China (Evaluate)

3/15/2022Biopharma Patents in China: Litigation, Licensing, and Patent Linkage ...

3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)

3/14/2022Chinese Investors' Interest In Cell And Gene Therapy Remains Strong

3/14/2022CDE Releases the Draft Guidelines for Clinical Trial of Improvement Ch...

3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility

3/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (52nd ...

3/11/2022CDE Solicits Comments on the Draft Procedures for Adjustment of Publis...

3/11/2022CDE Solicits Comments on the Draft Technical Guidelines for Protocol C...

3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines

3/11/2022Recent Executive Moves

3/11/2022Drug R&D and Product Registration News Digest March 2022 (2)

3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...

3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...

3/10/2022Zai Lab Revenue Triples, As It Struggles to Break Cycle of Mounting Lo...

3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)

3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha

3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China

3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China

3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...

Page:178/806 Total number of articles:24163: [First][<<] [176] [177] [178] [179] [180] [>>] [End]